학술논문

The poor outcome of patients with mCRPC whom were deemed ineligible for PSMA theranostics based on molecular imaging characteristics.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2018, 36 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755